AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

65 hedge funds and large institutions have $88.5M invested in Avadel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
23
Closed
15
Calls
$160K
Puts
$354K
Net Calls
-$194K
Net Calls Change
-$278K

Top Buyers

1
BIP
Brandes Investment Partners
California
+$5.99M
2
Morgan Stanley
Morgan Stanley
New York
+$1.3M
3
BC
Broadfin Capital
New York
+$299K
4
BCM
Brown Capital Management
Maryland
+$225K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$129K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$2.06M
2
Millennium Management
Millennium Management
New York
-$2.03M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.66M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$924K
5
GCP
GSA Capital Partners
United Kingdom
-$830K
Name Holding Trade Value Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -206 Closed
CHP
77
Cable Hill Partners
Oregon
– -$1K -100 Closed
1 2 3
4